Orthopedic & Spine Implants · Biologics & Biosimilars
Bioventus news and milestones
Bioventus: 24 headlines on record, 3 headlines in the last 90 days. Its story counts 3 milestones.
Data updated Nov 16, 2026 · Back to the company report
24Headlines
3In 90 days
3Milestones
Headlines
Oct 162026
News · MarketBeatMedia
Should You Buy or Sell Bioventus Stock? Get The Latest BVS Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
Oct 72026
News · Simply Wall St
If Bioventus was on your watchlist rather than in your portfolio, the outcome over the past few months may feel like a missed call. Investors who held Bioventus from the start of…
Sep 212026
News · Pluang
Bioventus is leveraging cash generated from its established orthopedic products to reduce debt and fund commercial expansion. The company has improved its financing terms by exte…
Aug 102026
News · YahooFinance
Bioventus stock has delivered strong share price gains over the past few years, yet current valuation checks still suggest it screens as relatively cheap on several metrics. That…
Aug 72026
News · Simply Wall St
Bioventus Inc. reported past second-quarter 2026 results with sales of US$153.21 million and net income of US$33.44 million, significantly lifting basic earnings per share from c…
Aug 62026
Aug 62026
News · Latham & Watkins LLP
Corporate team represents the medical product development company in evaluation of a range of strategic options.
Aug 62026
News · Simply Wall St
Bioventus stock jumped 13.7% today, and for once the emotional surge has a clear anchor in the numbers. The company just printed a muscular Q2 earnings story for a mid cap medica…
Aug 52026
News · Quiver Quantitative
Bioventus (BVS) reported second-quarter 2026 revenue of $153.2 million, up 4% from the prior-year period. Net income attributable to Bioventus Inc. was $33.4 million, compared wi…
Aug 52026
News · Quiver Quantitative
Bioventus reported Q2 revenue of $153.2 million, a 4% increase, and initiated a strategic alternatives review.Quiver AI SummaryBioventus Inc. reported a 4% increase in revenue fo…
Aug 52026
Press release · The Manila Times
Q2 reported revenue of $153.2 million increased 4%Q2 GAAP earnings of $0.47 per diluted share compared to the prior-year period earnings of $0.11 per diluted shareNon-GAAP earnin…
Jul 102026
News · Simply Wall St
Bioventus (BVS) is back in the spotlight as company leaders prepare to speak at the 26th Annual New Ideas Summer Investor Conference, giving investors fresh context for the stock…
Jun 252026
News · YahooFinance
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying a…
May 82026
Press release · The Globe and Mail
Detailed price information for Bioventus Inc Cl A (BVS-Q) from The Globe and Mail including charting and trades.
Oct 28, 20252025
Press release · The Manila Times
DURHAM, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (
May 21, 20252025
Apr 25, 20252025
News · Stock Titan
Bioventus Inc. (BVS) is a Nasdaq-listed medical technology company offering Pain Treatments, Surgical Solutions and Restorative Therapies for active healing.
Jan 16, 20252025
News · Reed Smith LLP
NEW YORK - Global law firm Reed Smith announced today that a cross-office private equity team led by Mark Pedretti, global chair of Reed Smith's private equity…
Dec 19, 20242024
News · BLaw
Bioventus' $15.25 million settlement over Exchange Act claims the pain medication company counted as revenue money that it'd have to return received final approval from a federal…
Oct 29, 20242024
Press release · The Manila Times
media450035
Dec 7, 20232023
Nov 27, 20232023
News · MedTechDive
Bioventus' protracted buyout bid ultimately fell apart and opened the door to Smith & Nephew.
Nov 16, 20202020
News · BioSpace
Bioventus , a global leader in Innovations For Active Healing, has appointed Chris Yamamoto as Senior Vice President of Business Development and Strategy. Yamamoto brings nearly…
Jan 29, 20192019
Press release · DutchNews.nl
Bioventus Launches DUROLANE in Malaysia and Selects Athrotech as Exclusive Distribution Partner
Sources: the outlets named on each headline, each story once
Milestones
Oct 2026
Went public NASDAQ: BVS
2012
Founded
Each milestone is dated by its source: registers, filings, the press
How to cite
Bioventus, News. Alion, Nov 16, 2026. https://alion.io/company/bioventus/news
